APA

Trbusek M., Malcikova J., Smardova J., Kuhrova V., Mentzlova D., Francova H., Bukovska S., Svitakova M., Kuglik P., Linkova V., Doubek M., Brychtova Y., Zacal J., Kujickova J., Pospisilova S., Dvorakova D., Vorlicek J. & Mayer J. (20061030). Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. : Leukemia.

Chicago

Trbusek M, Malcikova J, Smardova J, Kuhrova V, Mentzlova D, Francova H, Bukovska S, Svitakova M, Kuglik P, Linkova V, Doubek M, Brychtova Y, Zacal J, Kujickova J, Pospisilova S, Dvorakova D, Vorlicek J and Mayer J. 20061030. Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. : Leukemia.

Harvard

Trbusek M., Malcikova J., Smardova J., Kuhrova V., Mentzlova D., Francova H., Bukovska S., Svitakova M., Kuglik P., Linkova V., Doubek M., Brychtova Y., Zacal J., Kujickova J., Pospisilova S., Dvorakova D., Vorlicek J. and Mayer J. (20061030). Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. : Leukemia.

MLA

Trbusek M, Malcikova J, Smardova J, Kuhrova V, Mentzlova D, Francova H, Bukovska S, Svitakova M, Kuglik P, Linkova V, Doubek M, Brychtova Y, Zacal J, Kujickova J, Pospisilova S, Dvorakova D, Vorlicek J and Mayer J. Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. : Leukemia. 20061030.